COVID Vaccine

	Government panel recommends emergency approval for SII's Covovax for 7-11 year olds The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9. published on : 24th June 2022
	Kolkata Diary: Confusion over getting booster vaccine dose An committee member said it has been resolved that four of the five departments would admit candidates by awarding equal weightage to tests and Plus-2 marks. published on : 24th June 2022
	DCGI to review Serum Institute's applications for Covovax use in kids aged 2 to 7 yrs, 7 to 11 yrs The expert panel in its last meeting in April had sought more data from SII following its application seeking the emergency use authorization of Covovax for seven to 11 years. published on : 23rd June 2022
	Biological-E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine India's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age group of 12 to 14 years. published on : 22nd June 2022
	WHO approves Hyderabad firm to make vaccines for Johnson & Johnson "This is a great progress for Quad Vaccine and the US India Health partnership," said a US Embassy spokesperson. published on : 22nd June 2022
	Girl who lost sight day after taking Covid jab, seeks govt help to study medicine A 17-year-old girl who lost eyesight a day after she was administered with Covid vaccine at a Ranipet school sought the government’s help to study medicine. published on : 22nd June 2022
	FDA authorizes first COVID-19 vaccine shots for toddlers under age five The regulatory body has now approved Moderna shots for school-aged children and teens as well. published on : 17th June 2022
	WTO agrees to lift Covid vaccine patents, but is it 'too late' as India believes? Friday's compromise fell short of their earlier requests that the waiver apply to all countries -- and also cover Covid tests and treatments. published on : 17th June 2022
	Covaxin safe, well-tolerated in 2-18 years age-group, Bharat Biotech cites Lancet study A press release from the vaccine maker said the study has been accepted and published in Lancet Infectious diseases, peer reviewed high impact factor journal. published on : 17th June 2022
	After 111 days, single-day Covid count in India crosses 12,000 mark According to the ministry, cumulatively 195.67 doses of Covid vaccine have been administered in the country so far under the nationwide COVID-19 vaccination drive. published on : 16th June 2022
	Officials focus on vaccination as COVID cases rise in Coimbatore district On Friday, nine individuals tested positive, and it increased to 20 on Sunday and 14 on Monday with the the district having 37 active cases on June 6. published on : 15th June 2022
	Relax rule on third doses, urges Telangana Health Minister The Central government had started the inoculation of precautionary doses in January this year allowing third shots for healthcare and frontline workers and those above 60 years of age. published on : 14th June 2022
	Odisha battles huge pendency for second dose of COVID vaccine, over 30 lakh persons due The COVID vaccination for the 12-14 years age group had begun on March 16 and of an estimated 15.21 lakh children, 8.62 lakh have completed their vaccination. published on : 13th June 2022
	Tamil Nadu vaccinates 13.83 lakh people against COVID-19 in 30th mega inoculation drive According to department data, TN vaccinated 13,83,573 people, of which 2,44,520 received the first dose, 10,30,753 the second dose, and 1,08,300 the booster dose. published on : 13th June 2022
	Karnataka tops 11 crore in Covid-19 vaccination Karnataka on Saturday crossed the 11-crore mark in Covid-19 vaccinations. published on : 12th June 2022